DIA Annual Meeting

Virtual

June 27 - July 2, 2021

Virtual |

DIAmeeting.png

Recognizing and adapting to a new era of global change and uncertainty, DIA's key tenets remain unchanged.

Patients are our story, we seek to understand, collaboration is the skill we hone—and this collaboration must cross organizations, decades, languages, and boundaries to have a truly global impact.

The DIA 2021 Global Annual Meeting pushes beyond walls and borders. It is collaboration without boundaries, and we want you to join us and play a key role in building the framework of the future—making connections, gaining skills and insights, and advancing science to improve global health.

Visit Parexel in the virtual exhibit hall to find out what's new!
 

Join us for these presentations during DIA 2021
Tue, Jun 22 - 9:30am - 12:30pm
Medical Writing Training Programs: Teaching the Next Generation of Regulatory Medical Writers
Linda Yih, Senior Director, Medical Writing Services
Tue, Jun 29 - 10:00-11:00 am
Brave New World: Early Clinical Trials in a Pandemic
Sandra Stark, Head Early Phase Clinical Unit, Berlin
Anita Nelsen, Sr. Vice President, Translational Medicine
Thu, Jun 24 - 10:00am - 1:00pm
Short course: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Effecting Pharmaceutical Development
Alberto Grignolo, Corporate Vice President
Tue, Jan 29 - 2:00 - 3:00 pm
Epigenetic drugs' challenging and exciting road to the clinic
Sivakumar Gowrisankar, Scientific Director

 Fri, Jun 25 - 9:30am - 12:30pm
Short course: Regulatory Submissions and Interactions with NMPA: What You Need to Know
Chang Q. Lee, DrPH, MD, MS, Vice President, Regulatory and Access APAC

Wed, Jun 30 - 10:00 - 11:00 am
Targeting Cerebrospinal fluid (CSF) in early phase CNS drug development
Svetlana Semenova, Ph.D, Director, Scientific Affairs
Sun, Jun 27 - Thu, Jul 1 - 9:00 am - 5:00 pm

#ePosters: Professional and Student ePoster Gallery
Keith Wenzel, Senior Director, Scientific Data Organization

Wed, Jun 30 - 1:30 - 2:30 pm
Six Secrets for Successfully Leading Remote Teams
Chris Baker, Senior Vice President
Mon, Jun 28 - 12:00 - 12:30 pm
Results from a Survey of Biopharmaceutical on Attitudes Towards the Use of Wearables and Sensors in Clinical Research
Julia Lakeland, Sensor Solutions Senior
Director
Wed, Jun 30 - 2:00 - 3:00 pm
COVID-19 Pandemic and Beyond: Current Status and Learnings from Remote GMP Assessments
Mark Birse, Vice President, Technical
Mon, Jun 28 - 1:00 - 2:00 pm
Statistical Considerations with the Patient in Mind
Maciej Maruszczak, Consultant in Data Analytics and Machine Learning
Wed, Jun 30 - 2:00-3:00 pm
Antibody-Drug Conjugate Drug Development: From Novel Technology to New Patient Therapy

Presentation: The Evolution of Antibody-Drug Conjugates in the Era of Precision Medicine Development

Session chair & speaker: Angela Qu, VP, Translational Medicine
Mon, Jun 28 - 1:00 - 2:00 pm
Ensuring Representation in Early Phase Clinical Trials: The Importance of Diversity and Inclusion
Session chair & speaker: Lovingly Park, Ph.D., Director, Scientific Affairs
Wed, Jun 30 - 2:00 - 3:00 pm
The COVID-19 digital response of nations and companies - What is here to stay?
Michelle Hoiseth, Chief Data Officer
Tue, Jun 29 - 9:30 - 10:00 am
Acceleration of Clinical Research by Simultaneously Leveraging Real-World and Clinical Trials Data
Michelle Hoiseth, Chief Data Office
Thu, Jul 1 - 11:30 am - 12:30 pm
Accelerated Regulatory Strategies During a Pandemic: A Nonclinical Perspective
Gopala Krishna, Principal Consultant
Tue, Jun 29 - 10:00 - 11:00 am
Nonclinical safety evaluation strategies enabling IND and marketing for Cell and Gene therapy products
Zeck Huang, M.D., Ph.D., Senior Consultant, Regulatory & Access
Gopala Krishna, Principal Consultant, Regulatory & Access
Thu, Jul 1 - 2:00 - 3:00 pm
Incorporating Context for Comparisons in Observational Real-World Data: From Propensity Scores to Targeted Learning
Andy Wilson, Scientific Lead

EVENT WEBSITE

ADD TO CALENDAR

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference